Fluoroquinolone therapy for bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae
Background/Purpose: For extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae infections, carbapenems are recommended as first line therapy, and clinical data on the therapeutic efficacy of fluoroquinolones (FQs) is limited. This study compares the efficacy of FQs and carbapenems for...
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Artikel |
| Sprache: | English |
| Veröffentlicht: |
Elsevier
2017-06-01
|
| Schriftenreihe: | Journal of Microbiology, Immunology and Infection |
| Schlagworte: | |
| Online Zugang: | http://www.sciencedirect.com/science/article/pii/S168411821500835X |